Scarica l'app Stockscreener
10.68
0.47%
-0.05
Adma Biologics Inc Borsa (ADMA) Ultime notizie
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo! Finance Canada
(ADMA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
How Investors May Respond To ADMA Biologics (ADMA) Peer‑Reviewed Validation Of IVIG Safety And Purity - Yahoo Finance
Could ADMA Biologics' New IVIG Data Be A Catalyst For Investor Interest? - RTTNews
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process - Yahoo Finance
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ADMA Biologics Inc. Stock Grades | ADMA - Barron's
Can ADMA Biologics (NASDAQ:ADMA) Keep Scaling Its Plasma-Derived Pipeline? - Kalkine Media
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - Yahoo Finance
Intellia Therapeutics (NTLA) Soars 7.6%: Is Further Upside Left in the Stock? - Zacks Investment Research
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors - Zacks Investment Research
ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - Yahoo Finance
ADMA Biologics (ADMA), Why Is It Back In The Spotlight? - Yahoo Finance
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo! Finance Canada
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Eastern Progress
Why Adma Biologics (ADMA) Dipped More Than Broader Market Today - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - Yahoo Finance
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
ADMA Biologics Inc (ADMA) Stock Analysis: Potential Upside of 86.61% Sparks Investor Interest - DirectorsTalk Interviews
INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - mykxlg.com
Adma Biologics Stock Price Forecast. Should You Buy ADMA? - StockInvest.us
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
ADMA Biologics IncCommon Stock (Nasdaq:ADMA) Price Chart - The Chronicle-Journal
ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech Gem With 84% Upside Potential - DirectorsTalk Interviews
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance
ADMAAdma Biologics Inc Volatility & Greeks - Finviz
ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech With 76% Potential Upside - DirectorsTalk Interviews
ADMA: Adma Biologics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Trading Systems Reacting to (ADMA) Volatility - Stock Traders Daily
ADMA Biologics: Maybe The Bears Are Right (Rating Downgrade) (NASDAQ:ADMA) - Seeking Alpha
ADMA Biologics Inc (ADMA) Stock Analysis: Exploring A Promising 82% Potential Upside - DirectorsTalk Interviews
ADMA BIOLOGICS, INC. (ADMA) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - TMX Newsfile
Class action lawsuit filed against ADMA Biologics for misleading investors and undisclosed transactions - Pluang
Class action lawsuit filed against ADMA Biologics for misleading investors and undisclosed transactions - Pluang
Law firm probes ADMA Biologics' leadership for possible breaches of fiduciary duty - Pluang
ADMA BIOLOGICS, INC. (ADMA) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - TMX Newsfile
ADMA Biologics (ADMA) After Strong Q2 Results And Reaffirmed Guidance Is It A Bargain - Sahm
Nomura Small Cap Growth Fund's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
Investigation launched into ADMA Biologics for alleged revenue inflation via channel-stuffing. - Pluang
ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 79% Potential Upside for Investors - DirectorsTalk Interviews
ADMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
ADMA Biologics Inc (NASDAQ:ADMA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Bank of America Corp DE Raises Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Why ADMA Biologics (ADMA) Is Up 5.6% After Reaffirming 2026 Revenue Guidance And EPS Momentum - Sahm
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):